Event News

Organizers

Gold Sponsors

Banquet Sponsor

VC Partners

Supporting Partners

Media Partners

ChinaBio® Events

BioBay Investor Forum 2010

Suzhou, China

Nov. 3-4, 2010

China Forum 2010

Munich, Germany

November 14, 2010

ChinaBio® Investor Forum 2010 - Guangzhou

Guangzhou, China

December 21, 2010

Partner Events

BioPharm America™ 2010

Boston, MA, USA

September 15–17, 2010

CALAsia 2010

San Diego, USA

October 4-5, 2010

CHINA PRETRIALS 2010: Global Preclinical Development Summit

Beijing, China

October 17-19, 2010

companies

中文 English

Eighteen companies with novel technologies from the Pearl River Delta and throughout China will present at the ChinaBio® Investor Forum - Hong Kong in two tracks: drug development and services, device and diagnostics companies. All presenting companies have been screened and coached by ChinaBio® to ensure high quality presentations.

Company / Speaker
Type
Description
Adesso Biosciences, Inc.
Diag.
Carbon nanotube-based molecular diagnostic devices.
Drug Dev. 
Biopharmaceuticals based on intracellular proteins that display extracellular functions (Paul Schimmel).
 Drug Dev.
Specialty pharmaceutical company focused on oncology.
Drug Deliv.
Platforms for transmucosal, nasal, ophthalmic and lipidsomal drug delivery.
Service
Stem cell products and transgenic animal services for research.
Diag. 
Diagnostic services and products for prenatal and cancer detection.
Device 
Systems to treat liver failure using pig liver cells to cleanse blood. 
Cons. Prod. 
Nutritionally and physiologically correct premium drinks for sports, etc.
 Indus.
Low cost enzymes for medical, agricultural and industrial applications.
Diag. 
Molecular diagnostic and therapeutic products and novel sensor technology.
Drug Dev.
DNA-based biopharmaceuticals for veterinary applications.
 Drug Dev.
Spinoff of novel therapuetics for diabetes and metabolic diseases.
 Drug Dev.
TCM addressing irritable bowel syndrome showing efficacy in human trials.
Shenzhen Qianrenren Sci. & Tech. Development Co., Ltd.
Drug Dev.
Novel botanical drug for rheumatoid arthritis ready for Phase II. >>View video
Drug Dev.
Novel drug for liver tumor treatment in Phase II trials.
Diag. 
TK-1 based diagnostic products for cancer. Funded by Sequoia.
Sinoasis Pharma Ltd.
Drug Dev.
Peptide and antibody therapeutics for coronary heart diseases, cancer and diseases.
Versitech Limited (HKU)
Agri./ Energy
Transgenic plant technology to increase yield and biomass with applications in agriculture and bioenergy.>>View video